iA Global Asset Management Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1969566 Quebec, A8

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$18,815,563

-$12,370,286 QoQ

Shares Held

148,928

-33.4% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#331

of 2,265 holders

Holding Since

Jun 2023

13 quarters on record

Healthcare · as of Jun 30, 2026

iA Global Asset Management Inc. holds $187,071,908 across 8 Drug Manufacturers - General names. GILD ranks #4 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	346,960	$88,117,431
2	LLY	ELI LILLY & Co	32,937	$39,505,629
3	AMGN	Amgen Inc	62,971	$22,803,058
4	GILD	Gilead Sciences, Inc. This page	148,928	$18,815,563
5	MRK	Merck & Co., Inc.	69,634	$8,947,969
6	BMY	Bristol Myers Squibb Co	142,925	$8,235,338
7	PFE	Pfizer Inc	18,683	$449,886
8	ABBV	AbbVie Inc.	783	$197,034

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,815,563	148,928	-33.4%	Shares	Sole	2026-07-29
2026-03-31	$31,185,849	223,763	-4.9%	Shares	Sole	2026-04-23
2025-12-31	$28,891,154	235,385	+6.1%	Shares	Sole	2026-02-05
2025-09-30	$24,629,790	221,890	+11.6%	Shares	Sole	2025-10-30
2025-06-30	$22,045,834	198,844	+3.3%	Shares	Sole	2025-08-05
2025-03-31	$21,574,891	192,547	-3.7%	Shares	Sole	2025-05-09
2024-12-31	$18,463,100	199,882	+14.2%	Shares	Sole	2025-02-11
2024-09-30	$14,677,617	175,067	+14.5%	Shares	Sole	2024-11-15
2024-06-30	$10,486,283	152,839	-15.4%	Shares	Sole	2025-04-08
2024-03-31	$13,231,953	180,641	+4.8%	Shares	Sole	2024-05-15
2023-12-31	$13,957,293	172,291	+11.6%	Shares	Sole	2024-02-14
2023-09-30	$11,569,686	154,386	+32.4%	Shares	Sole	2023-11-15
2023-06-30	$8,988,134	116,623	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.